This certification will enable Kenyan manufacturer Universal Corporation Limited to support regional efforts to combat malaria through local production of high-quality sulfadoxine-pyrimethamine.
The pre-qualification was achieved with funding from global health agency Unitaid and support from MMV.
Pre-qualification is a service provided by W.H.O to assess the quality, safety and efficacy of medicinal products.
Young children and pregnant women are among the most vulnerable to the burden of malaria, with children under five accounting for 80 percent of all malaria deaths in Africa.
The lack of pre-qualified manufacturers in Africa raises concerns about the quality of medicines and supply insecurities that compromise the treatment of chronic and infectious diseases risks that were clearly revealed when COVID-19 disrupted global supply chains and left Africa with limited access to vital products.
Leave feedback about this